Results 41 to 50 of about 7,054 (204)

Ovarian cancer [PDF]

open access: yes, 2016
Ovarian cancer is not a single disease and can be subdivided into at least five different histological subtypes that have different identifiable risk factors, cells of origin, molecular compositions, clinical features and treatments.
A Bashashati   +219 more
core   +1 more source

Comparison of coagulation parameters associated with fibrinogen concentrate and cryoprecipitate for treatment of bleeding in patients undergoing cytoreductive surgery for pseudomyxoma peritonei: Subanalysis from a randomized, controlled phase 2 study

open access: yesHealth Science Reports, 2023
Background and Aims The FORMA‐05 study compared the efficacy and safety of human fibrinogen concentrate (HFC) versus cryoprecipitate for hemostasis in bleeding patients undergoing cytoreductive surgery for pseudomyxoma peritonei (PMP).
Ashok Roy   +7 more
doaj   +1 more source

Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [PDF]

open access: yes, 2009
Background: Peritoneal tumor dissemination arising from colorectal cancer, appendiceal cancer, gastric cancer, gynecologic malignancies or peritoneal mesothelioma is a common sign of advanced tumor stage or disease recurrence and mostly associated with ...
Gabriel Glockzin   +2 more
core   +1 more source

Hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma after cytoreductive surgical procedures: a systematic review

open access: yesWorld Journal of Surgical Oncology
Abstract Surgery-based multimodality therapies for treatment of malignant pleural mesothelioma have been clinically explored in the past decades. In this regard, hyperthermic intrathoracic or intrapleural chemotherapy has been used as one of the multimodality therapies.
Hany Hasan Elsayed   +4 more
openaire   +3 more sources

Role of primary surgery in advanced ovarian cancer [PDF]

open access: yes, 2004
Background Major issues in surgery for advanced ovarian cancer remain unresolved. Existing treatment guidelines are supported by a few published reports and fewer prospective randomized clinical trials.
Franke Folker E, Münstedt Karsten
core   +1 more source

Pelvic floor disorders in gynecological malignancies. An overlooked problem? [PDF]

open access: yes, 2018
Cervical, endometrial, ovarian, vulvar, and vaginal cancers affect women of a broad age spectrum. Many of these women are still sexually active when their cancer is diagnosed.
Bodean, Oana M.   +7 more
core   +3 more sources

Prognostic Factors of Peritoneal Metastases from Colorectal Cancer following Cytoreductive Surgery and Perioperative Chemotherapy

open access: yesThe Scientific World Journal, 2013
Background. Prolonged survival of patients affected by peritoneal metastasis (PM) of colorectal origin treated with complete cytoreduction followed by intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) has been reported. However, two-thirds
Yutaka Yonemura   +2 more
doaj   +1 more source

Fertility Preservation: A Key Survivorship Issue for Young Women with Cancer [PDF]

open access: yes, 2016
Fertility preservation in the young cancer survivor is recognized as a key survivorship issue by the American Society of Clinical Oncology and the American Society of Reproductive Medicine.
Amanda Nickles Fader   +3 more
core   +2 more sources

Metastatic spread of mucinous cystadenocarcinoma of the ovaries into abdominal wall [PDF]

open access: yes, 2005
Epithelial ovarian cancer belongs to the most common and most deadly of all types of ovarian carcinomas. Ovarian cancer affects women in the age group 65 years and older more frequently than younger women.
Koprivšek Katarina   +4 more
core   +1 more source

Cytoreductive Surgery in Patients With Metastatic Succinate Dehydrogenase‐Deficient Gastrointestinal Stromal Tumors

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Succinate dehydrogenase‐deficient (SDH‐deficient) gastrointestinal stromal tumors (GIST) are characterized by variable disease biology with poor responses to traditional tyrosine kinase inhibitors. The role of surgical intervention has been highly debated.
Katherine Y. Chen   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy